[go: up one dir, main page]

MA23921A1 - PROCESS FOR THE OPTICAL PURIFICATION OF COMPOUNDS - Google Patents

PROCESS FOR THE OPTICAL PURIFICATION OF COMPOUNDS

Info

Publication number
MA23921A1
MA23921A1 MA24295A MA24295A MA23921A1 MA 23921 A1 MA23921 A1 MA 23921A1 MA 24295 A MA24295 A MA 24295A MA 24295 A MA24295 A MA 24295A MA 23921 A1 MA23921 A1 MA 23921A1
Authority
MA
Morocco
Prior art keywords
compounds
optical purification
purification
optical
sulphinyl
Prior art date
Application number
MA24295A
Other languages
French (fr)
Inventor
Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA23921(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA23921A1 publication Critical patent/MA23921A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Process for the optical purification of the single enantiomers of some 2-sulphinyl-1H-benzimidazole derivatives and another structurally related sulphoxide from the respective enantiomerically enriched preparation thereof.
MA24295A 1995-07-03 1996-06-28 PROCESS FOR THE OPTICAL PURIFICATION OF COMPOUNDS MA23921A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03

Publications (1)

Publication Number Publication Date
MA23921A1 true MA23921A1 (en) 1996-12-31

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24295A MA23921A1 (en) 1995-07-03 1996-06-28 PROCESS FOR THE OPTICAL PURIFICATION OF COMPOUNDS

Country Status (36)

Country Link
US (1) US5929244A (en)
EP (2) EP1498416A1 (en)
JP (1) JP4195507B2 (en)
KR (1) KR100451078B1 (en)
CN (1) CN1098261C (en)
AT (1) ATE418549T1 (en)
AU (1) AU698638B2 (en)
BR (1) BR9609450A (en)
CA (1) CA2226184C (en)
CZ (1) CZ295430B6 (en)
DE (1) DE69637788D1 (en)
DK (1) DK0836601T3 (en)
DZ (1) DZ2057A1 (en)
EE (1) EE03444B1 (en)
ES (1) ES2318850T3 (en)
HR (1) HRP960232A2 (en)
HU (1) HUP9901717A3 (en)
IL (1) IL122811A (en)
IS (1) IS2666B (en)
MA (1) MA23921A1 (en)
MY (1) MY114018A (en)
NO (1) NO313008B1 (en)
NZ (1) NZ311842A (en)
PL (1) PL186702B1 (en)
PT (1) PT836601E (en)
RS (1) RS49826B (en)
RU (1) RU2144031C1 (en)
SA (1) SA96170103B1 (en)
SI (1) SI0836601T1 (en)
SK (1) SK284780B6 (en)
TN (1) TNSN96090A1 (en)
TR (1) TR199701754T1 (en)
TW (1) TW444010B (en)
UA (1) UA49838C2 (en)
WO (1) WO1997002261A1 (en)
ZA (1) ZA965205B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
AU6551198A (en) * 1997-05-30 1998-12-30 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
AU742620B2 (en) * 1998-01-30 2002-01-10 Sepracor, Inc. R-lansoprazole compositions and methods
SE9900274D0 (en) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CA2375091A1 (en) 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Crystals of benzimidazole compounds
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
EP1293507B1 (en) 2000-05-15 2007-11-28 Takeda Pharmaceutical Company Limited Process for producing crystal
ATE342263T1 (en) 2000-08-04 2006-11-15 Takeda Pharmaceutical SALTS OF BENZIMIDAZOLE DERIVATIVES AND THEIR USE
AU2002218506A1 (en) 2000-12-01 2002-06-11 Takeda Chemical Industries Ltd. Process for the crystallization of (r)- or (s)-lansoprazole
KR100433735B1 (en) * 2001-06-27 2004-06-04 주식회사 씨트리 Preparation method of Lansoprazole having crystalline form I
SE0104295D0 (en) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
JP2005521662A (en) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド Transmucosal delivery of proton pump inhibitors
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
DE10254167A1 (en) 2002-11-20 2004-06-09 Icon Genetics Ag Process for the control of cellular processes in plants
ME00563A (en) 2002-12-06 2011-12-20 Process for preparing optically pure active compounds
BR0316702A (en) 2002-12-06 2005-10-18 Altana Pharma Ag xprocess for preparation of -pantoprazole (s)
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
BRPI0407906A (en) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd s-omeprazole polymorphs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (en) * 2003-12-15 2005-06-17 Isochem Sa Enantiomeric enrichment of enantiomeric mixture of alpha-amino acids used as synthetic intermediates for pharmaceuticals involves cold precipitation of racemate from solvent and separating pure enantiomer from remaining solution
SE0400410D0 (en) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006009602A2 (en) 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
FR2876101B1 (en) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF SULFOXIDE DERIVATIVES
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (en) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa TENATOPRAZOLE POTASSIUM SALT CONGLOMERATES
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
KR101432866B1 (en) * 2007-06-15 2014-08-26 엠큐어 파마슈티컬즈 리미티드 A process of sulfoxidation of biologically active compounds
CN101323609B (en) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide
FR2920428B1 (en) * 2007-08-29 2012-06-15 Univ Rouen PROCESS FOR DEDOLDING SALTS OF OMEPRAZOLE
ES2638463T3 (en) 2008-03-10 2017-10-20 Takeda Pharmaceutical Company Limited Benzimidazole compound crystal
EP2346854A4 (en) 2008-11-18 2012-10-17 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (en) * 2008-12-12 2010-12-17 한미약품 주식회사 Method for preparing (R)-(+)-lansoprazole and intermediates used therein
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
US20130197232A1 (en) 2010-01-29 2013-08-01 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
JP6574773B2 (en) * 2014-07-30 2019-09-11 株式会社アエタスファルマ Optical isomers of 1,4-benzothiazepine-1-oxide derivatives and pharmaceutical compositions using the same
EP3064495B1 (en) * 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of optically pure esomeprazole

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (en) * 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
JPS6150978A (en) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd Pyridine derivative and preparation thereof
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (en) * 1986-11-13 1994-02-25 Eisai Co Ltd Process for Preparation as Drug Useful 2-Pyridin-2-yl-methylthio- and sulfinyl-1H-benzimidazole derivatives
DE69011645T2 (en) * 1989-11-29 1995-01-12 Toa Eiyo Ltd Cycloheptenopyridine derivatives, process for their preparation and antiulcer agents containing them.
DE4035455A1 (en) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab ENANTIOMER SEPARATION
SE9301830D0 (en) * 1993-05-28 1993-05-28 Ab Astra NEW COMPOUNDS
IS4232A (en) * 1993-12-06 1995-06-07 Astra Aktiebolag Substituted benzimidazole, its methods of manufacture and pharmacological use
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
EP0836601A1 (en) 1998-04-22
SA96170103B1 (en) 2006-07-30
IS2666B (en) 2010-08-15
IL122811A (en) 2000-11-21
UA49838C2 (en) 2002-10-15
WO1997002261A1 (en) 1997-01-23
CZ421197A3 (en) 1998-06-17
ATE418549T1 (en) 2009-01-15
HRP960232A2 (en) 1998-02-28
RS49826B (en) 2008-08-07
TNSN96090A1 (en) 2005-03-15
DE69637788D1 (en) 2009-02-05
EP0836601B1 (en) 2008-12-24
MX9800160A (en) 1998-03-31
PT836601E (en) 2009-02-17
EE9700368A (en) 1998-06-15
HUP9901717A3 (en) 2002-03-28
ZA965205B (en) 1997-01-03
SI0836601T1 (en) 2009-04-30
CN1193971A (en) 1998-09-23
YU37696A (en) 1999-03-04
DZ2057A1 (en) 2002-10-20
EP1498416A1 (en) 2005-01-19
JP4195507B2 (en) 2008-12-10
KR19990028631A (en) 1999-04-15
AU698638B2 (en) 1998-11-05
PL186702B1 (en) 2004-02-27
NO313008B1 (en) 2002-07-29
PL324394A1 (en) 1998-05-25
CA2226184C (en) 2008-08-05
NZ311842A (en) 1998-12-23
HUP9901717A2 (en) 2000-04-28
ES2318850T3 (en) 2009-05-01
SK179397A3 (en) 1998-09-09
HK1010193A1 (en) 1999-06-17
CZ295430B6 (en) 2005-08-17
NO976030L (en) 1998-02-09
IL122811A0 (en) 1998-08-16
KR100451078B1 (en) 2004-11-16
JPH11508590A (en) 1999-07-27
TW444010B (en) 2001-07-01
TR199701754T1 (en) 1998-04-21
BR9609450A (en) 1999-03-02
IS4638A (en) 1997-12-22
CA2226184A1 (en) 1997-01-23
NO976030D0 (en) 1997-12-22
CN1098261C (en) 2003-01-08
RU2144031C1 (en) 2000-01-10
MY114018A (en) 2002-07-31
EE03444B1 (en) 2001-06-15
SK284780B6 (en) 2005-11-03
DK0836601T3 (en) 2009-03-16
US5929244A (en) 1999-07-27
AU6324096A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
MA23921A1 (en) PROCESS FOR THE OPTICAL PURIFICATION OF COMPOUNDS
FR2742070B1 (en) PROCESS FOR THE CONTROLLED PRODUCTION OF SUPPORTED ZEOLITE MEMBRANES
EP0814956A4 (en) PRODUCTION OF OPTICAL ELEMENTS
MA23770A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
EP0846303A4 (en) IMPROVED PROCESS FOR THE PRODUCTION OF PROTOTYPES
EP0626410A3 (en) Process for the preparation of polycarbonates.
EP0744431A3 (en) Process for the preparation of aromatic polyamide
FR2704548B1 (en) Process for the production of trialcoxysilanes.
EP0719814A3 (en) Process for the preparation of polycarbonate
MA24534A1 (en) PROCESS FOR THE PRODUCTION OF IRONES
FR2754816B1 (en) PROCESS FOR THE PURIFICATION OF HYDROGENOCHLOROFLUOROETHANES
EP0729938A3 (en) Process for the preparation of aryl-alkyl-hydroperoxides
EE03393B1 (en) Process for the preparation of enantiomerically pure azetidine-2-carboxylic acid
MA23081A1 (en) PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVES
EP0763596A4 (en) PROCESS FOR THE PRODUCTION OF THROMBINE
FR2729387B1 (en) PROCESS FOR THE MANUFACTURE OF HYDROXY-ALCOXY-BENZOPHENONES
EP0719815A3 (en) Process for the preparation of polycarbonate
MA24015A1 (en) PROCESS FOR THE PREPARATION OF DIOXO-AZABICYCLOHEXANES
FR2585045B1 (en) METHOD FOR PREVENTING THE EFFECT OF BRIGHTNING PRODUCED BY OPTICAL BRIGHTENERS
FR2742450B1 (en) PROCESS FOR THE PRODUCTION OF HYPOCHLORITE
EP0673363A4 (en) PROCESS FOR THE PRODUCTION OF ALPHA-AMINONITRILES.
FR2737894B1 (en) PROCESS FOR THE PREPARATION OF ALKYLETAIN FLUORIDES
EP0747364A3 (en) Process for the preparation of 2,4,6-trichloropyrimidine
FR2790900B3 (en) METHOD FOR CONTROLLING THE QUALITY OF A DISTRIBUTED AUDIONUMERIC SIGNAL
FR2633059B1 (en) PROCESS FOR OBTAINING OPTICAL SURFACES